Psoriasis.
D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000963:Antimetabolites / Q000627:therapeutic use; D001372:Aza Compounds / Q000627:therapeutic use; D005938:Glucocorticoids; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D011565:Psoriasis / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology; D012459:Salicylates / Q000627:therapeutic use; D013638:Tars / Q000627:therapeutic use; D014529:Uridine / Q000031:analogs & derivatives / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D000963:Antimetabolites; D001372:Aza Compounds; D005938:Glucocorticoids; D012459:Salicylates; D013638:Tars; D014529:Uridine; D006918:Hydroxyurea; D008727:Methotrexate